{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T15:29:58Z","timestamp":1772638198962,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T00:00:00Z","timestamp":1658966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T00:00:00Z","timestamp":1658966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007316","name":"Division of Cancer Prevention, National Cancer Institute\/","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Qual Life Res"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s11136-022-03202-2","type":"journal-article","created":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T12:12:35Z","timestamp":1659010355000},"page":"3391-3401","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Health-related quality of life in long-term Caribbean prostate cancer survivors: comparisons with prostate cancer-free men"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7031-7244","authenticated-orcid":false,"given":"Maria D.","family":"Jackson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyn","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3081-4630","authenticated-orcid":false,"given":"Marshall K.","family":"Tulloch-Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,28]]},"reference":[{"issue":"10159","key":"3202_CR1","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","volume":"392","author":"GBD Disease","year":"2018","unstructured":"Disease, G. B. D., Injury, I., & Prevalence, C. (2018). Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet, 392(10159), 1789\u20131858.","journal-title":"Lancet"},{"issue":"4","key":"3202_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2991\/jegh.k.191008.001","volume":"9","author":"C Mattiuzzi","year":"2019","unstructured":"Mattiuzzi, C., & Lippi, G. (2019). Current cancer epidemiology. Journal of Epidemiology and Global Health, 9(4), 217\u2013222.","journal-title":"Journal of Epidemiology and Global Health"},{"issue":"28","key":"3202_CR3","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.1200\/JCO.2016.68.3870","volume":"34","author":"A Surbone","year":"2016","unstructured":"Surbone, A., & Tralongo, P. (2016). Categorization of cancer survivors: Why we need it. Journal of Clinical Oncology, 34(28), 3372\u20133374.","journal-title":"Journal of Clinical Oncology"},{"issue":"5","key":"3202_CR4","doi-asserted-by":"publisher","first-page":"479","DOI":"10.6004\/jnccn.2019.0023","volume":"17","author":"JL Mohler","year":"2019","unstructured":"Mohler, J. L., Antonarakis, E. S., Armstrong, A. J., D\u2019Amico, A. V., Davis, B. J., Dorff, T., Eastham, J. A., Enke, C. A., Farrington, T. A., Higano, C. S., Horwitz, E. M., Hurwitz, M., Ippolito, J. E., Kane, C. J., Kuettel, M. R., Lang, J. M., McKenney, J., Netto, G., Penson, D. F., \u2026 Freedman-Cass, D. A. (2019). Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 17(5), 479\u2013505.","journal-title":"Journal of the National Comprehensive Cancer Network"},{"issue":"21","key":"3202_CR5","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1001\/jama.2011.1745","volume":"306","author":"PL Nguyen","year":"2011","unstructured":"Nguyen, P. L., Je, Y., Schutz, F. A., Hoffman, K. E., Hu, J. C., Parekh, A., Beckman, J. A., & Choueiri, T. K. (2011). Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: A meta-analysis of randomized trials. JAMA, 306(21), 2359\u20132366.","journal-title":"JAMA"},{"issue":"1","key":"3202_CR6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1464-410X.2008.07539.x","volume":"102","author":"DA Galvao","year":"2008","unstructured":"Galvao, D. A., Spry, N. A., Taaffe, D. R., Newton, R. U., Stanley, J., Shannon, T., Rowling, C., & Prince, R. (2008). Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer. BJU International, 102(1), 44\u201347.","journal-title":"BJU International"},{"issue":"8","key":"3202_CR7","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.ejca.2006.01.029","volume":"42","author":"NA Spry","year":"2006","unstructured":"Spry, N. A., Kristjanson, L., Hooton, B., Hayden, L., Neerhut, G., Gurney, H., Corica, T., Korbel, E., Weinstein, S., & McCaul, K. (2006). Adverse effects to quality of life arising from treatment can recover with intermittent androgen suppression in men with prostate cancer. European Journal of Cancer, 42(8), 1083\u20131092.","journal-title":"European Journal of Cancer"},{"issue":"9","key":"3202_CR8","doi-asserted-by":"publisher","first-page":"e0239469","DOI":"10.1371\/journal.pone.0239469","volume":"15","author":"A Groarke","year":"2020","unstructured":"Groarke, A., Curtis, R., Skelton, J., & Groarke, J. M. (2020). Quality of life and adjustment in men with prostate cancer: Interplay of stress, threat and resilience. PLoS ONE, 15(9), e0239469.","journal-title":"PLoS ONE"},{"issue":"1","key":"3202_CR9","doi-asserted-by":"publisher","first-page":"E29","DOI":"10.1097\/NCC.0000000000000135","volume":"38","author":"HS Wu","year":"2015","unstructured":"Wu, H. S., & Harden, J. K. (2015). Symptom burden and quality of life in survivorship: A review of the literature. Cancer Nursing, 38(1), E29-54.","journal-title":"Cancer Nursing"},{"issue":"6","key":"3202_CR10","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1007\/s00520-019-05120-5","volume":"28","author":"S Adam","year":"2020","unstructured":"Adam, S., Doege, D., Koch-Gallenkamp, L., Thong, M. S. Y., Bertram, H., Eberle, A., Holleczek, B., Pritzkuleit, R., Waldeyer-Sauerland, M., Waldmann, A., Zeissig, S. R., Jansen, L., Rohrmann, S., Brenner, H., & Arndt, V. (2020). Age-specific health-related quality of life in disease-free long-term prostate cancer survivors versus male population controls-results from a population-based study. Supportive Care in Cancer, 28(6), 2875\u20132885.","journal-title":"Supportive Care in Cancer"},{"issue":"5","key":"3202_CR11","doi-asserted-by":"publisher","first-page":"e13076","DOI":"10.1111\/ecc.13076","volume":"28","author":"S Adam","year":"2019","unstructured":"Adam, S., Koch-Gallenkamp, L., Bertram, H., Eberle, A., Holleczek, B., Pritzkuleit, R., Waldeyer-Sauerland, M., Waldmann, A., Zeissig, S. R., Rohrmann, S., Brenner, H., & Arndt, V. (2019). Health-related quality of life in long-term survivors with localised prostate cancer by therapy-Results from a population-based study. European Journal of Cancer Care, 28(5), e13076.","journal-title":"European Journal of Cancer Care"},{"issue":"2","key":"3202_CR12","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00520-017-3880-8","volume":"26","author":"MA Annunziata","year":"2018","unstructured":"Annunziata, M. A., Muzzatti, B., Flaiban, C., Gipponi, K., Carnaghi, C., Tralongo, P., Caruso, M., Cavina, R., & Tirelli, U. (2018). Long-term quality of life profile in oncology: A comparison between cancer survivors and the general population. Supportive Care in Cancer, 26(2), 651\u2013656.","journal-title":"Supportive Care in Cancer"},{"issue":"2","key":"3202_CR13","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1080\/0284186X.2016.1266089","volume":"56","author":"V Arndt","year":"2017","unstructured":"Arndt, V., Koch-Gallenkamp, L., Jansen, L., Bertram, H., Eberle, A., Holleczek, B., Schmid-Hopfner, S., Waldmann, A., Zeissig, S. R., & Brenner, H. (2017). Quality of life in long-term and very long-term cancer survivors versus population controls in Germany. Acta Oncologica, 56(2), 190\u2013197.","journal-title":"Acta Oncologica"},{"issue":"11","key":"3202_CR14","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.3390\/cancers13112754","volume":"13","author":"D Doege","year":"2021","unstructured":"Doege, D., Thong, M. S. Y., Weisser, L., Koch-Gallenkamp, L., Jansen, L., Bertram, H., Eberle, A., Holleczek, B., Nennecke, A., Pritzkuleit, R., Waldmann, A., Zeissig, S. R., Brenner, H., & Arndt, V. (2021). Health-related quality of life in very long-term cancer survivors 14\u201324 Years post-diagnosis compared to population controls: A population-based study. Cancers (Basel), 13(11), 2754.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"3202_CR15","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s11764-014-0419-6","volume":"9","author":"FJ Drummond","year":"2015","unstructured":"Drummond, F. J., Kinnear, H., O\u2019Leary, E., Donnelly, C., Gavin, A., & Sharp, L. (2015). Long-term health-related quality of life of prostate cancer survivors varies by primary treatment. Results from the PiCTure (Prostate Cancer Treatment, your experience) study. Journal of Cancer Survivorship, 9(2), 361\u2013372.","journal-title":"Journal of Cancer Survivorship"},{"issue":"5","key":"3202_CR16","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1007\/s11764-018-0708-6","volume":"12","author":"H Gotze","year":"2018","unstructured":"Gotze, H., Taubenheim, S., Dietz, A., Lordick, F., & Mehnert, A. (2018). Comorbid conditions and health-related quality of life in long-term cancer survivors-associations with demographic and medical characteristics. Journal of Cancer Survivorship, 12(5), 712\u2013720.","journal-title":"Journal of Cancer Survivorship"},{"issue":"5","key":"3202_CR17","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., de Haes, J. C., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365\u2013376.","journal-title":"Journal of the National Cancer Institute"},{"issue":"4","key":"3202_CR18","first-page":"5","volume":"25","author":"B Gandek","year":"2004","unstructured":"Gandek, B., Sinclair, S. J., Kosinski, M., & Ware, J. E., Jr. (2004). Psychometric evaluation of the SF-36 health survey in Medicare managed care. Health Care Financing Review, 25(4), 5\u201325.","journal-title":"Health Care Financing Review"},{"key":"3202_CR19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ejca.2016.05.020","volume":"63","author":"C Kerleau","year":"2016","unstructured":"Kerleau, C., Guizard, A. V., Daubisse-Marliac, L., Heutte, N., Mercier, M., Grosclaude, P., Joly, F., & French Network of Cancer, R. (2016). Long-term quality of life among localised prostate cancer survivors: QALIPRO population-based study. European Journal of Cancer, 63, 143\u2013153.","journal-title":"European Journal of Cancer"},{"issue":"9","key":"3202_CR20","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1002\/cncr.22231","volume":"107","author":"F Mols","year":"2006","unstructured":"Mols, F., van de Poll-Franse, L. V., Vingerhoets, A. J., Hendrikx, A., Aaronson, N. K., Houterman, S., Coebergh, J. W., & Essink-Bot, M. L. (2006). Long-term quality of life among Dutch prostate cancer survivors: Results of a population-based study. Cancer, 107(9), 2186\u20132196.","journal-title":"Cancer"},{"issue":"6","key":"3202_CR21","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s10552-010-9520-y","volume":"21","author":"MD Jackson","year":"2010","unstructured":"Jackson, M. D., Walker, S. P., Simpson, C. M., McFarlane-Anderson, N., Bennett, F. I., Coard, K. C., Aiken, W. D., Tulloch, T., Paul, T. J., & Wan, R. L. (2010). Body size and risk of prostate cancer in Jamaican men. Cancer Causes and Control, 21(6), 909\u2013917.","journal-title":"Cancer Causes and Control"},{"issue":"1","key":"3202_CR22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/S0022-5347(17)59889-4","volume":"111","author":"DF Gleason","year":"1974","unstructured":"Gleason, D. F., & Mellinger, G. T. (1974). Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. Journal of Urology, 111(1), 58\u201364.","journal-title":"Journal of Urology"},{"issue":"7","key":"3202_CR23","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s10552-020-01306-z","volume":"31","author":"MD Jackson","year":"2020","unstructured":"Jackson, M. D., Tulloch-Reid, M. K., McCaw-Binns, A. M., Aiken, W., Ferguson, T. S., Bennett, N. R., Harrison, L., Badaloo, A., McGrowder, D., Grindley, A., Walker, E., & Anderson, S. G. (2020). Central adiposity at diagnosis may reduce prostate cancer-specific mortality in African-Caribbean men with prostate cancer: 10-year follow-up of participants in a case-control study. Cancer Causes and Control, 31(7), 651\u2013662.","journal-title":"Cancer Causes and Control"},{"key":"3202_CR24","unstructured":"WHO. (2000). Obesity: Preventing and managing the global epidemic."},{"issue":"11","key":"3202_CR25","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/j.ejca.2012.02.059","volume":"48","author":"K Cocks","year":"2012","unstructured":"Cocks, K., King, M. T., Velikova, G., de Castro Jr., G., Martyn St-James, M., Fayers, P. M., & Brown, J. M. (2012). Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. European Journal of Cancer, 48(11), 1713\u20131721.","journal-title":"European Journal of Cancer"},{"issue":"1","key":"3202_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1200\/JCO.1998.16.1.139","volume":"16","author":"D Osoba","year":"1998","unstructured":"Osoba, D., Rodrigues, G., Myles, J., Zee, B., & Pater, J. (1998). Interpreting the significance of changes in health-related quality-of-life scores. Journal of Clinical Oncology, 16(1), 139\u2013144.","journal-title":"Journal of Clinical Oncology"},{"issue":"10","key":"3202_CR27","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1002\/cncr.21865","volume":"106","author":"TO Blank","year":"2006","unstructured":"Blank, T. O., & Bellizzi, K. M. (2006). After prostate cancer: Predictors of well-being among long-term prostate cancer survivors. Cancer, 106(10), 2128\u20132135.","journal-title":"Cancer"},{"issue":"6","key":"3202_CR28","doi-asserted-by":"publisher","first-page":"E358","DOI":"10.1188\/15.ONF.E358-E367","volume":"42","author":"R Walker","year":"2015","unstructured":"Walker, R., Szanton, S. L., & Wenzel, J. (2015). Working toward normalcy post-treatment: A qualitative study of older adult breast and prostate cancer survivors. Oncology Nursing Forum, 42(6), E358-367.","journal-title":"Oncology Nursing Forum"},{"issue":"4","key":"3202_CR29","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2190\/DC07-CPVW-4UVE-5GK0","volume":"58","author":"KM Bellizzi","year":"2004","unstructured":"Bellizzi, K. M. (2004). Expressions of generativity and posttraumatic growth in adult cancer survivors. International Journal of Aging and Human Development, 58(4), 267\u2013287.","journal-title":"International Journal of Aging and Human Development"},{"issue":"2","key":"3202_CR30","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s11764-014-0403-1","volume":"9","author":"CR Leach","year":"2015","unstructured":"Leach, C. R., Weaver, K. E., Aziz, N. M., Alfano, C. M., Bellizzi, K. M., Kent, E. E., Forsythe, L. P., & Rowland, J. H. (2015). The complex health profile of long-term cancer survivors: Prevalence and predictors of comorbid conditions. Journal of Cancer Survivorship, 9(2), 239\u2013251.","journal-title":"Journal of Cancer Survivorship"},{"issue":"21","key":"3202_CR31","doi-asserted-by":"publisher","first-page":"5932","DOI":"10.12998\/wjcc.v9.i21.5932","volume":"9","author":"YH Luo","year":"2021","unstructured":"Luo, Y. H., Yang, Y. W., Wu, C. F., Wang, C., Li, W. J., & Zhang, H. C. (2021). Fatigue prevalence in men treated for prostate cancer: A systematic review and meta-analysis. World Journal of Clinical Cases, 9(21), 5932\u20135942.","journal-title":"World Journal of Clinical Cases"},{"issue":"6","key":"3202_CR32","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.jpainsymman.2014.11.296","volume":"49","author":"P Yates","year":"2015","unstructured":"Yates, P., Miaskowski, C., Cataldo, J. K., Paul, S. M., Cooper, B. A., Alexander, K., Aouizerat, B., Dunn, L., Ritchie, C., McCarthy, A., & Skerman, H. (2015). Differences in composition of symptom clusters between older and younger oncology patients. Journal of Pain and Symptom Management, 49(6), 1025\u20131034.","journal-title":"Journal of Pain and Symptom Management"},{"issue":"6","key":"3202_CR33","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1002\/pon.3150","volume":"22","author":"J Savard","year":"2013","unstructured":"Savard, J., Hervouet, S., & Ivers, H. (2013). Prostate cancer treatments and their side effects are associated with increased insomnia. Psycho-Oncology, 22(6), 1381\u20131388.","journal-title":"Psycho-Oncology"},{"issue":"4","key":"3202_CR34","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000494620","volume":"96","author":"LR Feng","year":"2019","unstructured":"Feng, L. R., Fuss, T., Dickinson, K., Ross, A., & Saligan, L. N. (2019). Co-occurring symptoms contribute to persistent fatigue in prostate cancer. Oncology, 96(4), 183\u2013191.","journal-title":"Oncology"},{"issue":"5","key":"3202_CR35","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/NCC.0b013e31819e23b7","volume":"32","author":"A Sammarco","year":"2009","unstructured":"Sammarco, A. (2009). Quality of life of breast cancer survivors: A comparative study of age cohorts. Cancer Nursing, 32(5), 347\u2013356.","journal-title":"Cancer Nursing"},{"issue":"7","key":"3202_CR36","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/pon.3480","volume":"23","author":"LP Forsythe","year":"2014","unstructured":"Forsythe, L. P., Alfano, C. M., Kent, E. E., Weaver, K. E., Bellizzi, K., Arora, N., Aziz, N., Keel, G., & Rowland, J. H. (2014). Social support, self-efficacy for decision-making, and follow-up care use in long-term cancer survivors. Psycho-Oncology, 23(7), 788\u2013796.","journal-title":"Psycho-Oncology"},{"issue":"5","key":"3202_CR37","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.eururo.2014.07.010","volume":"67","author":"PL Nguyen","year":"2015","unstructured":"Nguyen, P. L., Alibhai, S. M., Basaria, S., D\u2019Amico, A. V., Kantoff, P. W., Keating, N. L., Penson, D. F., Rosario, D. J., Tombal, B., & Smith, M. R. (2015). Adverse effects of androgen deprivation therapy and strategies to mitigate them. European Urology, 67(5), 825\u2013836.","journal-title":"European Urology"},{"issue":"19","key":"3202_CR38","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1200\/JCO.2014.57.8724","volume":"33","author":"M Brundage","year":"2015","unstructured":"Brundage, M., Sydes, M. R., Parulekar, W. R., Warde, P., Cowan, R., Bezjak, A., Kirkbride, P., Parliament, M., Moynihan, C., Bahary, J. P., Parmar, M. K., Sanders, K., Chen, B. E., & Mason, M. D. (2015). Impact of radiotherapy when added to androgen-deprivation therapy for locally advanced prostate cancer: Long-term quality-of-life outcomes from the NCIC CTG PR3\/MRC PR07 Randomized Trial. Journal of Clinical Oncology, 33(19), 2151\u20132157.","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"3202_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/07357907.2011.629381","volume":"30","author":"JW Moul","year":"2012","unstructured":"Moul, J. W., & Dawson, N. (2012). Quality of life associated with treatment of castration-resistant prostate cancer: A review of the literature. Cancer Investigation, 30(1), 1\u201312.","journal-title":"Cancer Investigation"},{"issue":"4","key":"3202_CR40","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s11136-019-02361-z","volume":"29","author":"MJM Geerkens","year":"2020","unstructured":"Geerkens, M. J. M., Pouwels, N. S. A., & Beerlage, H. P. (2020). The effectiveness of lifestyle interventions to reduce side effects of androgen deprivation therapy for men with prostate cancer: A systematic review. Quality of Life Research, 29(4), 843\u2013865.","journal-title":"Quality of Life Research"},{"issue":"11","key":"3202_CR41","doi-asserted-by":"publisher","first-page":"6259","DOI":"10.1007\/s00520-021-06132-w","volume":"29","author":"S Adam","year":"2021","unstructured":"Adam, S., Thong, M. S. Y., Martin-Diener, E., Camey, B., Egger Hayoz, C., Konzelmann, I., Mousavi, S. M., Herrmann, C., Rohrmann, S., Wanner, M., Staehelin, K., Strebel, R. T., Randazzo, M., John, H., Schmid, H. P., Feller, A., & Arndt, V. (2021). Identifying classes of the pain, fatigue, and depression symptom cluster in long-term prostate cancer survivors-results from the multi-regional Prostate Cancer Survivorship Study in Switzerland (PROCAS). Supportive Care in Cancer, 29(11), 6259\u20136269.","journal-title":"Supportive Care in Cancer"},{"issue":"1","key":"3202_CR42","doi-asserted-by":"publisher","first-page":"e12516","DOI":"10.1111\/ecc.12516","volume":"27","author":"EJM Pearson","year":"2018","unstructured":"Pearson, E. J. M., Morris, M. E., di Stefano, M., & McKinstry, C. E. (2018). Interventions for cancer-related fatigue: a scoping review. European Journal of Cancer Care (Engl), 27(1), e12516.","journal-title":"European Journal of Cancer Care (Engl)"},{"issue":"3","key":"3202_CR43","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.prnil.2020.11.001","volume":"9","author":"MS Kim","year":"2021","unstructured":"Kim, M. S., Jung, S. I., Chung, H. S., Chang Hwang, E., & Kwon, D. (2021). Effects of leuprolide acetate on the quality of life of patients with prostate cancer: A prospective longitudinal cohort study. Prostate International, 9(3), 132\u2013139.","journal-title":"Prostate International"},{"issue":"3","key":"3202_CR44","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s40271-016-0204-x","volume":"10","author":"LG Gordon","year":"2017","unstructured":"Gordon, L. G., Merollini, K. M. D., Lowe, A., & Chan, R. J. (2017). A Systematic review of financial toxicity among cancer survivors: We can\u2019t pay the co-pay. Patient, 10(3), 295\u2013309.","journal-title":"Patient"},{"issue":"1","key":"3202_CR45","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11764-018-0723-7","volume":"13","author":"A Pearce","year":"2019","unstructured":"Pearce, A., Tomalin, B., Kaambwa, B., Horevoorts, N., Duijts, S., Mols, F., van de Poll-Franse, L., & Koczwara, B. (2019). Financial toxicity is more than costs of care: The relationship between employment and financial toxicity in long-term cancer survivors. Journal of Cancer Survivorship, 13(1), 10\u201320.","journal-title":"Journal of Cancer Survivorship"},{"issue":"16","key":"3202_CR46","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1016\/j.ejca.2008.07.030","volume":"44","author":"G van Andel","year":"2008","unstructured":"van Andel, G., Bottomley, A., Fossa, S. D., Efficace, F., Coens, C., Guerif, S., Kynaston, H., Gontero, P., Thalmann, G., Akdas, A., D\u2019Haese, S., & Aaronson, N. K. (2008). An international field study of the EORTC QLQ-PR25: A questionnaire for assessing the health-related quality of life of patients with prostate cancer. European Journal of Cancer, 44(16), 2418\u20132424.","journal-title":"European Journal of Cancer"}],"container-title":["Quality of Life Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-022-03202-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11136-022-03202-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-022-03202-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T00:14:57Z","timestamp":1666484097000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11136-022-03202-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,28]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3202"],"URL":"https:\/\/doi.org\/10.1007\/s11136-022-03202-2","relation":{},"ISSN":["0962-9343","1573-2649"],"issn-type":[{"value":"0962-9343","type":"print"},{"value":"1573-2649","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,28]]},"assertion":[{"value":"9 July 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of The University of the West Indies (Mona) (May 19, 2014 \/ECP 155, 13\/14).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}